Latest Breaking News On - Company or anebulo - Page 3 : comparemela.com

Anebulo Pharmaceuticals Announces Positive Topline Data for ANEB-001 from a Phase 2 Clinical Trial for Acute Cannabinoid Intoxication

05.07.2022 - Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication (ACI) and substance abuse disorders (the “Company” or “Anebulo”), today . Seite 1

United statesSimon allenCompany or anebuloCentre for human drug researchAnebulo pharmaceuticals incAnebulo pharmaceuticalsChief executive officerHuman drug research

Anebulo Pharmaceuticals to Announce Topline Data for ANEB-001 from an Ongoing Phase 2 Clinical Trial for Acute Cannabinoid Intoxication on Tuesday July 5, 2022

Anebulo Pharmaceuticals to Announce Topline Data for ANEB-001 from an Ongoing Phase 2 Clinical Trial for Acute Cannabinoid Intoxication on Tuesday July 5, 2022
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Scott andersonSimon allenAnebulo teamAnebulo pharmaceuticals incCompany or anebuloCentre for human drug researchSecurities exchangeTuesday julyChief executive officerIndependence day holidayAnebulo pharmaceuticalsHuman drug researchSecurities actSecurities exchange actInvestor relationsPublic relations

Anebulo Pharmaceuticals Appoints Kenneth Cundy, Ph D , as Chief Scientific Officer

Anebulo Pharmaceuticals Appoints Kenneth Cundy, Ph D , as Chief Scientific Officer
morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomKenneth cundyScott andersonSimon allenAnebulo pharmaceuticalsUniversity of californiaXenoport incUniversity of manchesterAnebulo pharmaceuticals appoints kenneth cundyCohbar incGilead sciences incCentre for human drug researchCompany or anebuloAnebulo pharmaceuticals incSecurities exchange

Stock Market | Daily Herald

Stock Market | Daily Herald
dailyherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailyherald.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomKenneth cundySimon allenAnebulo pharmaceuticalsUniversity of californiaXenoport incUniversity of manchesterCohbar incGilead sciences incCentre for human drug researchCompany or anebuloAnebulo pharmaceuticals incSecurities exchangeUniversity of kentuckyEastman kodak company

Anebulo Pharmaceuticals : Doses More Than Half of the Subjects in Part A of a Phase 2 Clinical Trial and Provides Guidance on IND Submission - Form 8-K

Anebulo Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication and substance abuse disorder , today. | April 1, 2022

United statesScott andersonSimon allenAnebulo pharmaceuticalsAnebulo pharmaceuticals incCompany or anebuloCentre for human drug researchSecurities exchangeAnebulo pharmaceuticals doses more than halfProvides guidanceHuman drug researchChief executive officerSecurities actSecurities exchange actAnebulo pharmaceuticalInvestor relations